UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037143
Receipt number R000041222
Scientific Title Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn's disease patient in Japan. (SPREAD-J study)
Date of disclosure of the study information 2019/06/23
Last modified on 2023/02/04 12:19:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn's disease patient in Japan. (SPREAD-J study)

Acronym

SPREAD-J study

Scientific Title

Multicenter prospective registration study of efficacy and safety of capsule endoscopy in Crohn's disease patient in Japan. (SPREAD-J study)

Scientific Title:Acronym

SPREAD-J study

Region

Japan


Condition

Condition

Crohn's disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of study is to evaluate the efficacy, acceptability and safety of capsule endoscopy in Crohn's disease medical care.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Detection rate and frequency of Crohn's disease lesions by capsule endoscopy (CE)

Key secondary outcomes

Correlativity of existing Crohn's disease lesion activity evaluation methods (CDAI, CECDAI, Lewis Score), frequency of adverse events, capsule endoscopy acceptance evaluation, usage of patency capsules, and patency capsule related Adverse events


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit

80 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Patients diagnosed or suspected with CD who scheduled to have CE for all small bowel observation, and if necessary, were known gastrointestinal tract patency within 2 weeks prior to CE by some method including patency capsule.
2) Patients who understand the contents after receiving a written explanation, and receive written consent for free participation.
3) In the case of a minor, a patient who has obtained consent from a representative (guardian).

Key exclusion criteria

1) Patients with unknown digestive tract patency and patients with gastrointestinal obstruction or fistula.
2) Patients who can not receive CE (Patients with cardiac pacemaker insertion, or other electronic medical devices, or dysphagia or dysphagia symptoms).
3) Patients who are pregnant and may be pregnant.
4) In addition, patients who were judged to be unable to participate in research by responsible researcher or shared doctor.

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Masayuki
Middle name
Last name Saruta

Organization

The Jikei University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

105-8461

Address

3-25-8 Nishi-shinbashi, Minato-ku, Tokyo, 105-8461, JAPAN

TEL

03-3433-1111

Email

m.saruta@jikei.ac.jp


Public contact

Name of contact person

1st name Toshiyuki
Middle name
Last name Sakurai

Organization

The Jikei University School of Medicine

Division name

Division of Gastroenterology and Hepatology, Department of Internal Medicine

Zip code

105-8461

Address

3-25-8 Nishi-shinbashi, Minato-ku, Tokyo, 105-8461, JAPAN

TEL

03-3433-1111

Homepage URL


Email

to-sakurai@jikei.ac.jp


Sponsor or person

Institute

Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Division of Gastroenterology and Hepatology, Department of Internal Medicine, The Jikei University School of Medicine

Address

3-25-8 Nishi-shinbashi, Minato-ku, Tokyo, 105-8461, JAPAN

Tel

03-3433-1111

Email

to-sakurai@jikei.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 06 Month 23 Day


Related information

URL releasing protocol

https://hama-med-cr.net/CRNet_24/rinsho_shiken.aspx?stid=S024

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 09 Month 28 Day

Date of IRB

2018 Year 09 Month 28 Day

Anticipated trial start date

2018 Year 09 Month 28 Day

Last follow-up date

2021 Year 12 Month 31 Day

Date of closure to data entry

2022 Year 01 Month 31 Day

Date trial data considered complete

2022 Year 03 Month 31 Day

Date analysis concluded

2022 Year 08 Month 01 Day


Other

Other related information

To evaluate the usefulness, receptivity and safety of capsule endoscopy in Crohn's disease medical care


Management information

Registered date

2019 Year 06 Month 23 Day

Last modified on

2023 Year 02 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041222


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name